F13.932 maps to CMS-HCC V28 135. A source-labeled RAF reference is available. Confirm the documented diagnosis and applicable coding requirements. MEAT criteria · RAF Calculator · free HCC coding tools

ICD-10-CM Code View

HCC Buddy Code Card

Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.

Code lookupF13.932

Effective periodFY2026 Apr Update (Apr 1-Sep 30)

FY 2026 Apr update / Mental, Behavioral and Neurodevelopmental disorders (F01-F99) / Mental and behavioral disorders due to psychoactive substance use (F10-F19)

F13.932

Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidance

Sedative, hypnotic or anxiolytic use, unspecified with withdrawal with perceptual disturbances

A person is experiencing withdrawal from sedative, hypnotic, or anti-anxiety medications with perceptual disturbances such as hallucinations or illusions.

Buddy Insight

Withdrawal with perceptual disturbances from unspecified sedative use indicates hallucinations or illusions during withdrawal without full delirium.

Overview Risk Models Code Book Documentation Audit Notes Edition comparison

CMS-HCC V28

Mapped

HCC 135

Drug Use with Psychotic Compl...

Coefficient HCC 135: 0.424 (Community Non-Dual Aged (CNA))

CMS-HCC V24

Historical

Not used for standard CY2026 Medicare Advantage payment. Select a historical period to review V24.

Not used for CY2026 payment

ACA/HHS

Mapped

HCC 081

HHS-HCC 081 adult, RAF varies...

Code-level coefficient reference

ESRD/PACE

Mapped

HCC 54

Substance Use with Psychotic ...

Code-level coefficient reference

RXHCC

N/A

—

Not risk-adjusted for this model/period.

Not mapped

Code Book Path

Official

F13.9Sedative, hypnotic or anxiolytic-related use, unspecified F13.93Sedative, hypnotic or anxiolytic use, unspecified with withdrawal F13.932Sedative, hypnotic or anxiolytic use, unspecified with withdrawal with perceptual disturbances

Inclusion Terms

Official

No inclusion terms are included in this display for F13.932. Check the code and parent instructions in the Code Book.

Excludes 2

Official

symptoms, signs and abnormal clinical laboratory findings, not elsewhere classified (R00-R99)Inherited from F01-F99

Related Codes

Official

F13.930Sedative, hypnotic or anxiolytic use, unspecified with withdrawal, uncomplicated F13.931Sedative, hypnotic or anxiolytic use, unspecified with withdrawal delirium F13.939Sedative, hypnotic or anxiolytic use, unspecified with withdrawal, unspecified

Includes

Official

disorders of psychological developmentInherited from F01-F99

Excludes 1

Official

sedative, hypnotic or anxiolytic-related abuse (F13.1-)Inherited from F13.9, F13.93
sedative, hypnotic or anxiolytic-related dependence (F13.2-)Inherited from F13.9, F13.93
sedative, hypnotic or anxiolytic use, unspecified with intoxication (F13.92-)Inherited from F13.9, F13.93

Code First

Official

No Code First sequencing instructions are included in this display for F13.932. Check the code and parent instructions in the Code Book.

Use Additional

Official

No Use Additional Code instructions are included in this display for F13.932. Check the code and parent instructions in the Code Book.

Code Also

Official

No Code Also instructions are included in this display for F13.932. Check the code and parent instructions in the Code Book.

Buddy Documentation Tip

HCC Buddy guidance

Description of perceptual disturbances (hallucinations, illusions — visual, auditory, tactile)

Confirmation that full delirium criteria are NOT met

Timeline of substance cessation and onset of perceptual symptoms

Withdrawal severity assessment (CIWA-B or equivalent)

MEAT Support

HCC Buddy guidance

Description of perceptual disturbances (hallucinations, illusions — visual, auditory, tactile)

Confirmation that full delirium criteria are NOT met

Timeline of substance cessation and onset of perceptual symptoms

Withdrawal severity assessment (CIWA-B or equivalent)

Audit Caution

HCC Buddy guidance

Coding this as withdrawal delirium when the patient maintains orientation but has hallucinations

Coding uncomplicated withdrawal when perceptual disturbances are documented

Not monitoring for delirium progression in a patient with perceptual disturbances

Using an unspecified use code when the withdrawal context strongly suggests dependence

Common Mistakes

HCC Buddy guidance

F13.931 — Unspecified use with withdrawal delirium; full delirium with disorientation

F13.930 — Unspecified use with withdrawal uncomplicated; no perceptual disturbances

F13.232 — DEPENDENCE with withdrawal perceptual disturbance; use when dependence is confirmed

F13.951 — Unspecified use with induced hallucinations; occurs during active use, not withdrawal

Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →

Is F13.932 an HCC code?

Yes. F13.932 (Sedative, hypnotic or anxiolytic use, unspecified with withdrawal with perceptual disturbances) maps to HCC 135, Drug Use with Psychotic Complications under the CMS-HCC V28 risk adjustment model, with a source-labeled community non-dual aged reference coefficient of 0.424. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes. It is billable for payment year 2026.

Coder answer: F13.932 is billable and maps to V28 HCC 135, Drug Use with Psychotic Complications. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.

Code: F13.932
Description: Sedative, hypnotic or anxiolytic use, unspecified with withdrawal with perceptual disturbances
HCC (V28): HCC 135 — Drug Use with Psychotic Complications
RAF reference coefficient: 0.424
Billable: Yes
Payment year: 2026

HCC Category Mapping

V28HCC 135, Drug Use with Psychotic Complications

0.424

ESRDHCC 54, Substance Use with Psychotic Complications

Not separately weighted

These are source-labeled model coefficients, not member totals. A category may still be removed by hierarchy or model cleanup rules. Weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member context, hierarchy and cleanup rules, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains available for historical review.

Work F13.932 in the Code Book — tabular path, V28 RAF reference, and MEAT checklist →

MEAT review for F13.932

For F13.932, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule.

MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
EEvaluate: test results, medication response, or physical findings reviewed by the provider
AAssess: explicit mention in the assessment or plan with acknowledgment of status
TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis

Coder workflow notes

Get the V28 mapping + MEAT cheat sheet

One printable reference: check representative V28 mappings and the documentation reminders your note needs. Free, no card.

Free PDF. No card. Unsubscribe anytime.

What This Code Means

F13.932 is the ICD-10-CM diagnosis code for sedative, hypnotic or anxiolytic use, unspecified with withdrawal with perceptual disturbances. A person is experiencing withdrawal from sedative, hypnotic, or anti-anxiety medications with perceptual disturbances such as hallucinations or illusions. F13.932 sits in the ICD-10-CM chapter for mental, behavioral and neurodevelopmental disorders (f01-f99), within the section covering mental and behavioral disorders due to psychoactive substance use (f10-f19).

Under the CMS-HCC V28 risk adjustment model, F13.932 maps to Drug Use with Psychotic Complications (HCC 135) with a source-labeled community, non-dual, aged reference coefficient of 0.424. For CY2026 non-PACE Medicare Advantage, CMS uses 100% of the 2024 CMS-HCC model (V28). PACE uses a separate model blend. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes.

Distinguish between withdrawal with perceptual disturbances (this code) and withdrawal delirium (F13.931) - perceptual disturbances occur without full delirium. For F13.932, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.

HCC Buddy maintains structured V28 and V24 mapping, source-labeled coefficient references, and MEAT documentation criteria for F13.932 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.

Coding Tips

•Distinguish between withdrawal with perceptual disturbances (this code) and withdrawal delirium (F13.931) - perceptual disturbances occur without full delirium
•Document specific perceptual symptoms and timeline to differentiate from other psychiatric conditions

Clinical Significance

Withdrawal with perceptual disturbances from unspecified sedative use indicates hallucinations or illusions during withdrawal without full delirium. This is a critical warning sign of potential progression to withdrawal delirium and indicates significant neurological disturbance. The perceptual symptoms reflect central nervous system hyperexcitability during withdrawal from sedatives.

Documentation Requirements

✓Description of perceptual disturbances (hallucinations, illusions — visual, auditory, tactile)
✓Confirmation that full delirium criteria are NOT met
✓Timeline of substance cessation and onset of perceptual symptoms
✓Withdrawal severity assessment (CIWA-B or equivalent)
✓Monitoring plan for potential delirium progression
✓Substance identification if possible

Commonly Confused Codes

•F13.931: Unspecified use with withdrawal delirium; full delirium with disorientation
•F13.930: Unspecified use with withdrawal uncomplicated; no perceptual disturbances
•F13.232: DEPENDENCE with withdrawal perceptual disturbance; use when dependence is confirmed
•F13.951: Unspecified use with induced hallucinations; occurs during active use, not withdrawal
•F13.939: Unspecified use with withdrawal unspecified; use when complications cannot be assessed